相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Sumit Gupta et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Discontinuation of l-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia
Ikuya Usami et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
Birgitte Klug Albertsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16
Sima Jeha et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
Nicolas Boissel et al.
BLOOD (2018)
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
Hagop Kantarjian et al.
LANCET ONCOLOGY (2018)
Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
Veerle Mondelaers et al.
HAEMATOLOGICA (2017)
Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
Veerle Mondelaers et al.
HAEMATOLOGICA (2017)
Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model
Chengcheng Liu et al.
PLOS ONE (2016)
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia A Children's Oncology Group Study
Smita Bhatia et al.
JAMA ONCOLOGY (2015)
Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
Kjeld Schmiegelow et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial
Ajay Vora et al.
LANCET ONCOLOGY (2014)
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
Jitesh D. Kawedia et al.
BLOOD (2012)
Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia
Reid Merryman et al.
PEDIATRIC BLOOD & CANCER (2012)
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub et al.
BLOOD (2011)
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951
Barbara De Moerloose et al.
BLOOD (2010)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A. Moericke et al.
LEUKEMIA (2010)
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004)
Anjo J. Veerman et al.
LANCET ONCOLOGY (2009)
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Ching-Hon Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Nita L. Seibel et al.
BLOOD (2008)
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial
Valentino Conter et al.
LANCET (2007)
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies:: results of a randomized European Organisation for Research and Treatment of Cancer -: Children's Leukemia Group phase 3 trial
M Duval et al.
BLOOD (2002)
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
BJ Lange et al.
BLOOD (2002)
分享论文
